DZ2549A1 - Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan. - Google Patents

Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan.

Info

Publication number: DZ2549A1
Authority: DZ; Algeria
Prior art keywords: pct; pharmaceutical compositions; compositions containing; eletriptan hemisulfate; containing eletriptan
Prior art date: 1997-07-03

Application number

DZ980159A

Other languages

English (en)

French (fr)

Inventor

Valerie Denise Harding

Anne Billotte

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-03

Filing date

1998-07-01

Publication date

2003-02-08

1997-07-03 Priority claimed from GBGB9714081.8A external-priority patent/GB9714081D0/en

1998-07-01 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2003-02-08 Application granted granted Critical

2003-02-08 Publication of DZ2549A1 publication Critical patent/DZ2549A1/xx

Links

IYVZCNNIKYUHHM-WXMGBDCWSA-N OS(O)(=O)=O.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 Chemical compound OS(O)(=O)=O.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 IYVZCNNIKYUHHM-WXMGBDCWSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
229960001948 caffeine Drugs 0.000 abstract 1
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DZ980159A 1997-07-03 1998-07-01 Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan. DZ2549A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9714081.8A GB9714081D0 (en)	1997-07-03	1997-07-03	Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en)	1997-07-03	1997-08-28	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
DZ2549A1 true DZ2549A1 (fr)	2003-02-08

Family

ID=26311826

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ980159A DZ2549A1 (fr)	1997-07-03	1998-07-01	Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan.

Country Status (30)

Country	Link
US (1)	US6166025A (xx)
EP (1)	EP0999841B1 (xx)
JP (1)	JP3350061B2 (xx)
CN (1)	CN1145486C (xx)
AT (1)	ATE206921T1 (xx)
AU (1)	AU724728B2 (xx)
BG (1)	BG103930A (xx)
BR (1)	BR9810658A (xx)
CA (1)	CA2292673C (xx)
DE (1)	DE69802097T2 (xx)
DK (1)	DK0999841T3 (xx)
DZ (1)	DZ2549A1 (xx)
EA (1)	EA002174B1 (xx)
ES (1)	ES2163291T3 (xx)
HR (1)	HRP990416B1 (xx)
HU (1)	HUP0004468A3 (xx)
ID (1)	ID24528A (xx)
IL (1)	IL133206A0 (xx)
IS (1)	IS5283A (xx)
MA (1)	MA26518A1 (xx)
NO (1)	NO312993B1 (xx)
NZ (1)	NZ501419A (xx)
OA (1)	OA11227A (xx)
PL (1)	PL337803A1 (xx)
PT (1)	PT999841E (xx)
SI (1)	SI0999841T1 (xx)
SK (1)	SK284462B6 (xx)
TR (1)	TR199903332T2 (xx)
UY (1)	UY25078A1 (xx)
WO (1)	WO1999001135A1 (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9816556D0 (en) *	1998-07-30	1998-09-30	Pfizer Ltd	Therapy
GB9825988D0 (en)	1998-11-27	1999-01-20	Pfizer Ltd	Indole derivatives
GB9922963D0 (en) *	1999-09-28	1999-12-01	Pfizer Ltd	Polymorphic salt
WO2000064448A1 (en)	1999-04-27	2000-11-02	Board Of Regents, The University Of Texas System	A composition and method for treatment of cerebral ischemia
GB9915231D0 (en)	1999-06-29	1999-09-01	Pfizer Ltd	Pharmaceutical complex
CO5190678A1 (es) *	1999-06-30	2002-08-29	Pfizer Prod Inc	Terapia combinada para el tratamiento de la migrana
IL136961A0 (en) *	1999-06-30	2001-06-14	Pfizer Prod Inc	5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine
CO5190664A1 (es) *	1999-06-30	2002-08-29	Pfizer Prod Inc	Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
GB9923314D0 (en)	1999-10-01	1999-12-08	Pfizer Ltd	Acylation process
US6579898B2 (en) *	2001-03-01	2003-06-17	Pfizer Inc.	Compositions having improved bioavailability
WO2003020977A2 (en) *	2001-08-31	2003-03-13	The University Court Of The University Of Glasgow	Nucleotide repeats assay
US7404489B1 (en)	2003-03-04	2008-07-29	Qol Medical, Llc	Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
US7132549B2 (en)	2003-05-30	2006-11-07	Pfizer Inc.	Process
GB0312478D0 (en) *	2003-05-30	2003-07-09	Pfizer Ltd	Improved process
GB2407498B (en) *	2003-10-30	2008-06-11	Cipla Ltd	Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
US20080286388A1 (en) *	2004-10-22	2008-11-20	Shin-Jen Shiao	Pharmaceutical Composition and Non Dependence Coffee Comprising Edible Carboxylic Acid and/or Its Acid Salts and Coffeine
US8506934B2 (en)	2005-04-29	2013-08-13	Robert I. Henkin	Methods for detection of biological substances
JP2009504767A (ja) *	2005-08-17	2009-02-05	フレミング・アンド・カンパニー・ファーマシューティカルズ	ビタミンｂ１２鼻用スプレーおよび使用方法
US20070041905A1 (en) *	2005-08-19	2007-02-22	Hoffman Rebecca S	Method of treating depression using a TNF-alpha antibody
US8293489B2 (en)	2007-01-31	2012-10-23	Henkin Robert I	Methods for detection of biological substances
FR2926721B1 (fr) *	2008-01-30	2011-07-22	Philippe Perovitch	Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
US8580801B2 (en)	2008-07-23	2013-11-12	Robert I. Henkin	Phosphodiesterase inhibitor treatment
JP5776355B2 (ja) *	2010-07-16	2015-09-09	大正製薬株式会社	内服液剤
US8915245B2 (en) *	2010-10-07	2014-12-23	Vapotherm, Inc.	Nebulizer systems, apparatus and methods for respiratory therapy
JP5887894B2 (ja) *	2010-12-10	2016-03-16	大正製薬株式会社	内服液剤
JP5887893B2 (ja) *	2010-12-10	2016-03-16	大正製薬株式会社	内服液剤
ES2744542T3 (es) *	2013-03-15	2020-02-25	Robert I Henkin	Inhibidores de fosfodiesterasa para tratar trastornos gustativos y olfativos
AU2014306244B2 (en)	2013-08-08	2018-03-29	Vapotherm, Inc.	Respiratory therapy condensation adaptor
NL1040474C2 (en)	2013-10-31	2015-05-04	Veramed B V	Nasal compositions stimulating ciliary activity.
WO2015126944A1 (en)	2014-02-18	2015-08-27	Henkin Robert I	Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
JP6097787B2 (ja) *	2015-06-09	2017-03-15	パルファーマシューティカル，インコーポレーテッド	鼻内送達用シアノコバラミン低粘度水性製剤
FR3053334B1 (fr) *	2016-06-30	2018-07-27	L'oreal	Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et de compose de xanthine
WO2024243498A2 (en) *	2023-05-24	2024-11-28	Defuse Technologies, LLC	Desensitized fertilizer compositions and methods of making same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents

1998
- 1998-07-01 TR TR1999/03332T patent/TR199903332T2/xx unknown
- 1998-07-01 CN CNB988066289A patent/CN1145486C/zh not_active Expired - Fee Related
- 1998-07-01 NZ NZ501419A patent/NZ501419A/xx unknown
- 1998-07-01 IL IL13320698A patent/IL133206A0/xx unknown
- 1998-07-01 SK SK1828-99A patent/SK284462B6/sk unknown
- 1998-07-01 DK DK98940152T patent/DK0999841T3/da active
- 1998-07-01 CA CA002292673A patent/CA2292673C/en not_active Expired - Fee Related
- 1998-07-01 EP EP98940152A patent/EP0999841B1/en not_active Expired - Lifetime
- 1998-07-01 HU HU0004468A patent/HUP0004468A3/hu unknown
- 1998-07-01 SI SI9830068T patent/SI0999841T1/xx unknown
- 1998-07-01 ES ES98940152T patent/ES2163291T3/es not_active Expired - Lifetime
- 1998-07-01 PL PL98337803A patent/PL337803A1/xx unknown
- 1998-07-01 DE DE69802097T patent/DE69802097T2/de not_active Expired - Fee Related
- 1998-07-01 US US09/402,239 patent/US6166025A/en not_active Expired - Fee Related
- 1998-07-01 DZ DZ980159A patent/DZ2549A1/xx active
- 1998-07-01 MA MA25150A patent/MA26518A1/fr unknown
- 1998-07-01 JP JP50638199A patent/JP3350061B2/ja not_active Expired - Fee Related
- 1998-07-01 HR HR970276A patent/HRP990416B1/xx not_active IP Right Cessation
- 1998-07-01 ID IDW991585A patent/ID24528A/id unknown
- 1998-07-01 AU AU88569/98A patent/AU724728B2/en not_active Ceased
- 1998-07-01 WO PCT/EP1998/004176 patent/WO1999001135A1/en not_active Ceased
- 1998-07-01 EA EA199901100A patent/EA002174B1/ru not_active IP Right Cessation
- 1998-07-01 BR BR9810658-9A patent/BR9810658A/pt not_active Application Discontinuation
- 1998-07-01 PT PT98940152T patent/PT999841E/pt unknown
- 1998-07-01 AT AT98940152T patent/ATE206921T1/de not_active IP Right Cessation
- 1998-07-01 UY UY25078A patent/UY25078A1/es not_active IP Right Cessation
1999
- 1999-11-30 IS IS5283A patent/IS5283A/is unknown
- 1999-11-30 BG BG103930A patent/BG103930A/xx unknown
- 1999-12-01 NO NO19995887A patent/NO312993B1/no unknown
- 1999-12-03 OA OA9900271A patent/OA11227A/en unknown

Also Published As

Publication number	Publication date
AU724728B2 (en)	2000-09-28
HRP990416B1 (en)	2002-04-30
DE69802097D1 (de)	2001-11-22
NO995887L (no)	2000-03-02
TR199903332T2 (xx)	2000-09-21
HRP990416A2 (en)	2000-04-30
JP3350061B2 (ja)	2002-11-25
NO312993B1 (no)	2002-07-29
CA2292673A1 (en)	1999-01-14
PT999841E (pt)	2002-02-28
PL337803A1 (en)	2000-09-11
WO1999001135A1 (en)	1999-01-14
EP0999841A1 (en)	2000-05-17
CN1261279A (zh)	2000-07-26
EA002174B1 (ru)	2002-02-28
AU8856998A (en)	1999-01-25
ID24528A (id)	2000-07-20
SK182899A3 (en)	2000-09-12
NZ501419A (en)	2000-09-29
EA199901100A1 (ru)	2000-08-28
CA2292673C (en)	2003-04-22
DE69802097T2 (de)	2002-03-14
IS5283A (is)	1999-11-30
UY25078A1 (es)	2000-12-29
CN1145486C (zh)	2004-04-14
HK1029282A1 (en)	2001-03-30
IL133206A0 (en)	2001-03-19
BR9810658A (pt)	2000-10-03
OA11227A (en)	2003-07-18
JP2000516262A (ja)	2000-12-05
HUP0004468A2 (hu)	2001-10-28
BG103930A (en)	2000-07-31
MA26518A1 (fr)	2004-12-20
NO995887D0 (no)	1999-12-01
DK0999841T3 (da)	2001-11-19
US6166025A (en)	2000-12-26
HUP0004468A3 (en)	2004-07-28
EP0999841B1 (en)	2001-10-17
SK284462B6 (sk)	2005-04-01
ATE206921T1 (de)	2001-11-15
SI0999841T1 (xx)	2001-12-31
ES2163291T3 (es)	2002-01-16

Publication	Publication Date	Title
DZ2549A1 (fr)	2003-02-08	Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan.
DE69727922D1 (de)	2004-04-08	Schnell zerfallende orale dosierungsform
ATE219765T1 (de)	2002-07-15	Indolderivate als cgmp-pde inhibitoren
MA27311A1 (fr)	2005-05-02	Utilisation d'inhibiteurs de cetp et facultativement d'inhibiteurs de hmg-coa-reductase et/ou d'agents antihypertensifs
IL133825A0 (en)	2001-04-30	Substituted 6-phenylphenanthridines, medicaments containing same and use thereof
HUT73807A (en)	1996-09-30	5-ht1-like indole derivatives and pharmaceutical compositions containing them
ATE310738T1 (de)	2005-12-15	Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
TR200101262T2 (tr)	2001-12-21	Uzun süreli salınımlı ranolazin formülasyonları
MA27729A1 (fr)	2006-01-02	Compositions pharmaceutiques solides contenant un agoniste des recepteurs de la s1p et un alcool de sucre
FR2757157B1 (fr)	1999-12-31	Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
TR200101499T1 (tr)	2002-09-23	Azepinoindol türevleri, hazırlanmaları ve kullanımları.
TNSN04034A1 (en)	2006-06-01	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
ATE213940T1 (de)	2002-03-15	Parenteral anzuwendende arzneizubereitung enthaltend amiodaron
IT1314185B1 (it)	2002-12-06	Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
FR2685918B1 (fr)	1995-06-23	Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2763592B1 (fr)	1999-07-16	Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
MA27731A1 (fr)	2006-01-02	Combinaison comprenant paroxetine et 2-(s) - (4-fluoro-2-methyl-phenyl) -piperazine-1-acide carboxylique [1- (r)-(3,5-bis-trifluoro-2-methyl-phenyl) -ethyl]-methyl amide destinee au traitement de la depression et/ou de l'anxiete
FR2700166B1 (fr)	1995-02-17	Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
AU2001237768A1 (en)	2001-09-12	Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
MY119643A (en)	2005-06-30	Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
IT1314204B1 (it)	2002-12-06	Complessi di rutenio con elevata attivita' antitumorale
ECSP982578A (es)	1999-02-11	Composiciones farmaceuticas que contienen eletriptan hemisulfato